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E D I T O R I A L
2019 Overview
The CNS Neuroscience & Therapeutics provides a medium for rapid 
publication of original clinical, experimental, and translational re-
search papers, timely reviews, and reports of novel findings of ther-
apeutic relevance to the central nervous system. Its focus includes 
clinical pharmacology, drug development, and novel methodologies 
for drug evaluation in neurological and psychiatric diseases. We are 
pleased to announce that CNS Neuroscience & Therapeutics has be-
come an Open-Access Journal as of January 2019. This would allow 
wider dissemination of scientific knowledge and facilitate collab-
orative efforts toward advancing novel and solid research on the 
maintenance of brain homeostasis and repairing the aging and dys-
functional brain.
Over the past year, the Journal covered the latest advancements 
and future directions in clinical neuroscience with an emphasis on 
mitochondrial biology, cerebrovascular disease, brain stimulation, 
and microglia through four special issues. Specifically, the special 
issue on Mitochondria in Neurodegenerative Diseases highlights 
how modifiable factors like caloric restriction and exercise can in-
fluence mitochondria biogenesis and effective removal following 
damage, and how disruption of mitochondria quality control mech-
anisms can lead to neurodegenerative diseases like Parkinson's, 
Huntington's, and Alzheimer's disease.1-3 It also updates our current 
understanding of nonmodifiable factors like genetics and posttrans-
lational modifications on mitochondrial dynamics and their implica-
tions in neurological disease. In the special issue on Hemorrhagic 
Stroke—Pathomechanisms of Injury and Therapeutic Options, we 
review the molecular changes responsible for direct and secondary 
brain injury following cerebral hemorrhage and interventions like 
hyperbaric oxygen preconditioning that may help attenuate these 
damages.4 We also discuss the potential use of magnetic resonance 
imaging (MRI) as an image-based biomarker for monitoring treatment 
and long-term clinical outcomes of interventions targeting iron-me-
diated toxicity. The special issue on Toward Personalized Brain 
Stimulation: Advances and Challenges highlights the progress of 
brain stimulation in clinical practice and the mechanisms underlying 
stimulation-induced changes in cognitive dysfunction in neurologi-
cal and psychiatric disorders. Lastly, the special issue on Microglia/
Macrophage Diversities in CNS Injuries and Diseases covers various 
disease-specific microglia/macrophage profiles. Although their roles 
in CNS homeostasis and response to neuronal injury have yet to be 
fully understood, microglia clearly play an integral role in the pro-
gression of CNS injuries and disease. Further studies exploring their 
phenotypic variety and underlying mechanism will hopefully lead to 
therapeutic strategies that modulate microglia response.
In the coming year, CNSNT will have a variety of special issues 
including Traumatic Brain Injury.
We are delighted to invite proposals for Special Issues on focus 
topics with high current interest. Recognized experts are encour-
aged to organize and guest edit special issues with the journal.
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